Revelation of a Novel CLN5 Mutation in Early Juvenile Neuronal Ceroid Lipofuscinosis

Abstract

Neuronal ceroid lipofuscinoses (NCLs) are relatively common storage diseases of childhood and early adolescence. Ultrastructural shape of storage cytosomes, type of disease gene, and age of onset serve to classify the different NCLs, some of which appear to cluster in Scandinavian countries. The CLN5 form usually presents as a classical epileptiform encephalopathy of late infancy but a more aggressive cognitive impairment has been described in a single family. We report two sibs harbouring a novel mutation (p.Tyr258Asp) in the CLN5 gene and displaying behaviour disturbances and mental deterioration, rather than epilepsy, as the dominant disease manifestation at onset.

Key words

Neuronal ceroid lipofuscinoses - CLN5 gene - storage disease - Scandanavia - mutation

References

• 1 Bessa C, Teixeira CA, Mangas M, Dias A, Sá Miranda MC, Guimarães A. et al . Two novel CLN5 mutations in a Portuguese patient with vLINCL: Insights into molecular mechanisms of CLN5 deficiency.  Mol Genet Metab. 2006;  89 245-253
• 2 Bonsignore M, Tessa A, Di Rosa G, Piemonte F, Dionisi-Vici C, Simonati A. et al . Novel CLN1 mutation in two Italian sibs with late infantile neuronal ceroid lipofuscinosis.  Eur J Paediatr Neurol. 2006;  10 154-156
• 3 Cannelli N, Cassandrini D, Bertini E, Striano P, Fusco L, Gaggero R. et al . Novel mutations in CLN8 in Italian variant late infantile neuronal ceroid lipofuscinosis: another genetic hit in the Mediterranean.  Neurogenetics. 2006;  7 111-117
• 4 den Hollander AI, van Driel MA, de Kok YJ, van de Pol DJ, Hoyng CB, Brunner HG. et al . Isolation and mapping of novel candidate genes for retinal disorders using suppression subtractive hybridization.  Genomics.. 1999;  58 240-249
• 5 Holmberg V, Lauronen L, Autti T, Santavuori P, Savukoski M, Uvebrant P. et al . Phenotype-genotype correlation in eight patients with Finnish variant late infantile NCL (CLN5).  Neurology. 2000;  55 579-581
• 6 Holmberg V, Jalanko A, Isosomppi J, Fabritius AL, Peltonen L, Kopra O. The mouse ortholog of the neuronal ceroid lipofuscinosis CLN5 gene encodes a soluble lysosomal glycoprotein expressed in the developing brain.  Neurobiol Dis. 2004;  16 29-40
• 7 Holopainen JM, Saarikoski J, Kinnunen PK, Jarvela II. Elevated lysosomal pH in neuronal ceroid lipofuscinoses (NCLs).  Eur J Biochem. 2001;  268 5851-5856
• 8 McGuffin LJ, Bryson K, Jones DT. The PSIPRED protein structure prediction server.  Bioinformatics. 2000;  16 404-405
• 9 Mole SE, Williams RE, Goebel HH. Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses.  Neurogenetics. 2005;  6 107-126
• 10 Pineda-Trujillo N, Cornejo W, Carrizosa J, Wheeler RB, Munera S, Valencia A. et al . A CLN5 mutation causing an atypical neuronal ceroid lipofuscinosis of juvenile onset.  Neurology. 2005;  64 740-742
• 11 Savukoski M, Klockars T, Holmberg V, Santavuori P, Lander ES, Peltonen L. CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis.  Nat Genet. 1998;  19 286-288
• 12 Siintola E, Lehesjoki AE, Mole SE. Molecular genetics of the NCLs - status and perspectives.  Biochim Biophys Acta. 2006;  1762 857-864
• 13 Vesa J, Chin MH, Oelgeschäger K, Isosomppi J, DellAngelica EC, Jalanko A. et al . Neuronal ceroid lipofuscinoses are connected at molecular level: interaction of CLN5 protein with CLN2 and CLN3.  Mol Biol Cell. 2002;  13 2410-2420

Correspondence